Physician profile
Wilson Z Ray
NPI 1669575619
$586,294.53
in general payments reported to CMS, 2019-2025
35 companies · $161K in 2025
The $161K reported for 2025 was more than what 98% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94K · 2020: $38K · 2021: $62K · 2022: $56K · 2023: $61K · 2024: $114K · 2025: $161K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $242K · Travel and Lodging: $34K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $31K · Royalty Or License: $23K · Food and Beverage: $6,424.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $241,898.00 |
| Travel and Lodging | $33,832.16 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $30,587.50 |
| Royalty Or License | $23,127.00 |
| Food and Beverage | $6,424.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $326,453.01 | 2019-2025 | Excelsius Gps, Excelsiusgps Robotic Navigation System, Xlif |
| Medical Device Business Services, INC. | $107,962.64 | 2019-2025 | Expedium, Conduit, Viper |
| Expanding Innovations, INC. | $55,149.37 | 2021-2025 | X-Pac |
| Depuy Synthes Products, INC. | $31,679.96 | 2019-2025 | Expedium |
| Corelink, LLC | $19,133.19 | 2020-2023 | |
| Pacira Pharmaceuticals Incorporated | $11,011.53 | 2021 | |
| Depuy Synthes Sales INC. | $10,659.72 | 2019-2025 | |
| Orthofix Medical, INC. | $5,090.61 | 2019-2025 | Miscellaneous, Laminoplasty, Northstar |
| Bioventus LLC | $3,397.58 | 2023-2024 | Bonescalpel, Bonescalpel & Sonicone (O.R.) |
| Alphatec Spine, INC | $3,357.28 | 2023-2024 | Other - Miscellaneous, Biologics |
| Medtronic, INC. | $3,009.33 | 2021-2025 | Mazor X System, Cd Horizon Spinal System, Midas Rex |
| Nuvasive, INC. | $2,514.15 | 2019-2022 | |
| Medacta USA, INC. | $2,089.17 | 2025 | Myspine, Mecta |
| Carbofix Spine INC | $1,666.66 | 2021 | |
| Zavation Medical Products, LLC | $1,465.06 | 2023-2024 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Augmedics INC. | $393.75 | 2020-2024 | Xvision |
| Tulavi Therapeutics, INC. | $298.84 | 2025 | Allay Nerve Cap - Small Nerve Set |
| Axogen | $244.17 | 2020 | |
| Integra Lifesciences Corporation | $156.40 | 2024-2025 | Codman Certas, Duraseal Exact Spinal Sealant System, Codman Hakim |
| Aesculap Implant Systems, LLC | $140.19 | 2024 | Activl |
| Boston Scientific Corporation | $128.60 | 2022 | |
| 4web, INC. | $118.50 | 2024 | Spine Truss System |
| Kuros Biosciences USA, INC | $52.72 | 2021 | |
| Vb Spine LLC | $32.71 | 2025 | Ozark Cervical Plate System |
| Viseon, INC. | $19.29 | 2022 | |
| Centinel Spine, LLC | $18.63 | 2025 | Prodisc L |
| Stryker Corporation | $18.49 | 2022 | |
| Cerapedics INC. | $18.29 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Medtronic USA, INC. | $14.69 | 2020 |
6 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$223,131.25 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wilson Ray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.